Abdi Ibrahim

Abdi İbrahim is a century-old, privately-held Turkish pharmaceutical powerhouse with a fully integrated business model spanning R&D, manufacturing, and commercialization. It maintains a diverse portfolio of branded generics and specialty medicines, supported by major production facilities in Turkey, Kazakhstan, and Algeria. The company is expanding its international footprint through subsidiaries and strategic partnerships, while investing in sustainability, talent development, and social innovation programs to secure future growth.

Integrated small-molecule pharmaceutical platform focused on formulation development, process optimization, and generic/biosimilar development, supported by advanced manufacturing (Esenyurt Complex, Abdibio Center) and a dedicated R&D Center.

In Turkey, Abdi İbrahim competes with other domestic pharma firms and multinational corporations for market share. Globally, it competes in the generic and specialty medicine space against large Indian, European, and other international generic manufacturers. Its competitive advantages include strong domestic brand loyalty, integrated manufacturing, and a broad therapeutic portfolio.